Popular Clinical
Trials Searches
Trials Searches
- Obesity
- Leukemia
- Healthy
- Diabetic Neuropathies
- Gastrointestinal Diseases
- HIV Infections
- Newly Diagnosed Cancer Patients
- Spinal Muscular Atrophy Type I
- Ovarian Stimulation
- Healthy Students
- Violence
- Non-cancer Affected Volunteers
- Breast Cancer
- Non Resectable Metastasis
- Bladder, Neurogenic
- Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL)
- Nephrosis
- Locally Advanced Non Small-Cell Lung Canger
- Alpha-1 Antitrypsin Deficiency
- Non-melanoma Skin Cancer
- Neisseria Gonorrhoeae
- Dyslexia
- Urolithiasis
- Non-cancer Pain
- Acral Melanoma
Terrestrial Trunked Radio (TETRA) and Cognitive Functions in Healthy Subjects
Overview:
Status: Recruiting
Study State Date: April 2010
Primary Completion Date: Anticipated June 2013
Study Type: Interventional
Study Design: Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Basic Science
Phase: N/A
Study State Date: April 2010
Primary Completion Date: Anticipated June 2013
Study Type: Interventional
Study Design: Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Basic Science
Phase: N/A
Sponsor(s):
Charite University, Berlin, Germany
The Federal Office for Radiation Protection
The Federal Office for Radiation Protection
Trial Identifier: NCT01117597
Official Title: Experimental Study on Possible Effects of Radiofrequency (RF) Signal Characteristics Used for the TETRA Standard on Cognitive Functions in Healthy Subjects
Description: The purpose of this study is to analyse a possible effect of radiofrequency (RF) fields used for Terrestrial Trunked Radio (TETRA) of brain activity and cognitive functions in occupationally exposed subjects.
Eligibility:
Accepts Healthy Volunteers?: Accepts Healthy VolunteersEnrollment: 30 Anticipated
Minimum Age: 18 Years
Maximum Age: 30 Years
Gender(s): Male
Additional Criteria: Inclusion Criteria: - healthy male subjects - right handed - potential TETRA users - alpha-EEG - non-smokers Exclusion Criteria: - acute illness - severe neurological, psychiatric or internal disease - ZNS-active medication - sleep disorders - drug abuse
Conditions:
Healthy
Healthy
Interventions:
Radiation: RF exposure
Radiation: RF exposure
Radiation: RF exposure
Radiation: RF exposure
Radiation: RF exposure
Radiation: RF exposure
Primary Outcome Measures:
Performance in cognitive tests
Time Frame: acute effect under exposure will be assessed for a period of 3 hours for 9 test sessions (two weeks apart, three sessions for every exposure condition)
Safety Issue: No
Time Frame: acute effect under exposure will be assessed for a period of 3 hours for 9 test sessions (two weeks apart, three sessions for every exposure condition)
Safety Issue: No
Secondary Outcome Measures:
Sleep quality
Time Frame: acute effect under exposure will be assessed for a period of approximately 8 hours for 9 experimental nights (two weeks apart, three nights for every exposure condition)
Safety Issue: No
Time Frame: acute effect under exposure will be assessed for a period of approximately 8 hours for 9 experimental nights (two weeks apart, three nights for every exposure condition)
Safety Issue: No
Patient Groups:
Assigned Interventions:
low RF exposure level: Experimental
Radiation: RF exposure
sham: Sham Comparator
Radiation: RF exposure
high RF exposure level: Experimental
Radiation: RF exposure
Location & Contacts:
Contacts:Cornelia Sauter, PhD +493084458634 cornelia.sauter@charite.de
Anita Peter, MD +493084458630 anita.peter@charite.de
Investigators:
Study Director: Blanka Pophof, PhD, The Federal Office for Radiation Protection
Principal Investigator: Heidi Danker-Hopfe, PhD, Charite University, Berlin, Germany
Responsible Party:
Charité University Medicine Berlin (Heidi Danker-Hopfe, Professor PhD)
Study Locations:
+ Show All 1 Study Locations
Germany
Competence Sleep Medicine CC15, Charité University Medicine Berlin (Recruiting)
Berlin, Germany
Contact: Cornelia Sauter, PhD +493084458634 cornelia.sauter@charte.de
Latest Clinical
Trials News
Trials News
Diabetes Clinical Trials search for new treatments and cures
03/14/2010
03/14/2010
There are a number of clinical trials underway to find effective treatments for diabetes, including new drugs, surgery and even transplantation.
Feeling Depressed? A clinical trial might help.
03/07/2010
03/07/2010
There are several current and ongoing trials of interventions for major depressive disorder, which is characterized by a disabling combination of symptoms causing severe disruption to the sufferer's ability to carry out routine functions and tasks of daily life.
The State of Constipation Clinical Trials
02/28/2010
view more...
02/28/2010
Constipation is a illness where the bowels cannot move waste material out of the body in a normal manner. There are various clinical trials recruiting participants to study the effectiveness of various treatments.
